Blockchain Registration Transaction Record

Clene Presents Preliminary Data on CNM-Au8(R) as Potential Treatment for Rett Syndrome

Clene Inc. presents preliminary data on the potential of CNM-Au8(R) as a treatment for Rett Syndrome, a rare pediatric neurologic disorder. The data show neuroprotective effects and rescue of mitochondrial deficits in Rett patients, expanding the company's central thesis of developing CNM-Au8 as a treatment for multiple nervous system diseases.

This news matters as it demonstrates the potential of a new treatment for Rett Syndrome, a severe pediatric neurologic disorder, and expands the scope of Clene's central thesis of developing CNM-Au8 as a treatment for multiple nervous system diseases.